PegBio Co., Ltd.
2Patents
2Active
2Granted
43Portfolio score
Filing activity: Apr 23, 2010 → Dec 28, 2016 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8575097B2 | Exendin variant and conjugate thereof | Human Necessities | 16 | Active |
| US10894076B2 | Composition comprising GLP-1 receptor agonist and glucagon receptor agonist and application thereof | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.